Equity Capital Markets

Company · CIK 1586049

Oxford Immunotec Global PLC

CIK1586049 (SEC EDGAR)
Industry (SIC)2835 — In Vitro & In Vivo Diagnostic Substances
Incorporated inX0
Business addressUnited Kingdom
Listedno ticker on SEC record today
First annual or quarterly report2014-03-27

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-215236
ShelfEffective
 2016-12-212017-08-164
333-200571
ShelfEffective
 2014-11-252015-01-304
333-191737
IPOFinal prospectus
 2013-10-152013-11-2510

Filings

19
FiledFilingRegistrationAccession
2017-08-16424B5Shelf takedown 333-2152360001437749-17-014903
2017-08-15424B5Shelf takedown 333-2152360001437749-17-014775
2017-01-27EFFECTDeclared effective 333-2152369999999995-17-000226
2016-12-21S-3Shelf registered 333-2152360001437749-16-043660
2015-01-30424B5Shelf takedown 333-2005710001437749-15-001510
2015-01-28424B5Shelf takedown 333-2005710001437749-15-001372
2014-12-11EFFECTDeclared effective 333-2005719999999995-14-003669
2014-11-25S-3Shelf registered 333-2005710001437749-14-021349
2013-11-25424B4Final prospectus 333-1917370001193125-13-452975
2013-11-21EFFECTDeclared effective 333-1917379999999995-13-003342
2013-11-19S-1/AAmendment 333-1917370001193125-13-446798
2013-11-14S-1/AAmendment 333-1917370001193125-13-442397
2013-11-08S-1/AAmendment 333-1917370001193125-13-435508
2013-11-07S-1/AAmendment 333-1917370001193125-13-432305
2013-11-05S-1/AAmendment 333-1917370001193125-13-427860
2013-11-04S-1/AAmendment 333-1917370001193125-13-423474
2013-10-25S-1/AAmendment 333-1917370001193125-13-411727
2013-10-15S-1Registration filed 333-1917370001193125-13-400058
2013-09-10DRSDraft made public 377-003100000950123-13-007429

All filings of this company · CSV